The Use of Thalidomide in Myeloma Therapy as an Effective Anticancer Drug

Publisher： Bentham Science Publishers

E-ISSN： 1873-5576|6|4|325-331

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.6, Iss.4, 2006-06, pp. : 325-331

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Thalidomide: a new anticancer drug?

By Fanelli Massimo   Sarmiento Roberta   Gattuso Domenico   Carillio Guido   Capaccetti Barbara   Vacca Angelo   Roccaro Aldo Maria   Gasparini Giampietro  

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 7, 2003-07 ,pp. : 1211-1225

Informa Healthcare

Access to resources Recommend Favorite

Thalidomide as an Antiangiogenic Drug in the Treatment of Multiple Myeloma

By  

Letters in Drug Design & Discovery, Vol. 1, Iss. 2, 2004-04 ,pp. : 135-136

Bentham Science Publishers

Access to resources Recommend Favorite

Thalidomide is effective when added to dexamethasone for the treatment of newly diagnosed multiple myeloma

By  

Inpharma, Vol. 1, Iss. 1527, 2006-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Thalidomide in multiple myeloma – clinical trials and aspects of drug metabolism and toxicity

By Breitkreutz Iris   Anderson Kenneth C  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 4, Iss. 7, 2008-07 ,pp. : 973-985

Informa Healthcare

Access to resources Recommend Favorite

Thalidomide - most significant drug in decades for multiple myeloma?

By  

Inpharma, Vol. 1, Iss. 1225, 2000-01 ,pp. : 11-12

Adis International

Access to resources Recommend Favorite